Estimates of costs for modelling return on investment from smoking cessation interventions
Autor/a
Trapero-Bertran, Marta
Leidl, Reiner
Muñoz, Celia
Kulchaitanaroaj, Puttarin
Coyle, Kathryn
Präger, Maximilian
Józwiak‐Hagymásy, Judit
Cheung, Kei Long
Hiligsmann, Mickaël
Pokhrel, Subhash
EQUIPT Study Group
Data de publicació
2018ISSN
1360-0443
Resum
Background and aims: Modelling return on investment (ROI) from smoking cessation interventions requires estimates of their costs and benefits. This paper describes a standardized method developed to source both economic costs of tobacco smoking and costs of implementing cessation interventions for a Europe‐wide ROI model [European study on Quantifying Utility of Investment in Protection from Tobacco model (EQUIPTMOD)]. Design: Focused search of administrative and published data. A standardized checklist was developed in order to ensure consistency in methods of data collection. Setting and participants: Adult population (15+ years) in Hungary, Netherlands, Germany, Spain and England. For passive smoking‐related costs, child population (0–15 years) was also included. Measurements: Costs of treating smoking‐attributable diseases; productivity losses due to smoking‐attributable absenteeism; and costs of implementing smoking cessation interventions. Findings: Annual costs (per case) of treating smoking attributable lung cancer were between €5074 (Hungary) and €52 106 (Germany); coronary heart disease between €1521 (Spain) and €3955 (Netherlands); chronic obstructive pulmonary disease between €1280 (England) and €4199 (Spain); stroke between €1829 (Hungary) and €14 880 (Netherlands). Costs (per recipient) of smoking cessation medications were estimated to be: for standard duration of varenicline between €225 (England) and €465 (Hungary); for bupropion between €25 (Hungary) and €220 (Germany). Costs (per recipient) of providing behavioural support were also wide‐ranging: one‐to‐one behavioural support between €34 (Hungary) and €474 (Netherlands); and group‐based behavioural support between €12 (Hungary) and €257 (Germany). The costs (per recipient) of delivering brief physician advice were: €24 (England); €9 (Germany); €4 (Hungary); €33 (Netherlands); and €27 (Spain). Conclusions: Costs of treating smoking‐attributable diseases as well as the costs of implementing smoking cessation interventions vary substantially across Hungary, Netherlands, Germany, Spain and England. Estimates for the costs of these diseases and interventions can contribute to return on investment estimates in support of national or regional policy decisions.
Tipus de document
Article
Versió del document
Versió acceptada
Llengua
English
Matèries (CDU)
33 - Economia
Paraules clau
Hàbit de fumar
Tabac
Tabaquisme -- Tractament
Cost
Gestió de la rendabilitat
Inversions
Tabaco -- Consumo
Tabaco
Tabaquismo -- Tratamiento
Costes
Gestión de rentabilidad
Inversiones
Smoking -- Habit
Tobacco
Smoking -- Treatment
Costs
Profit -- Management
Investments
Pàgines
10
Publicat per
Wiley
Col·lecció
113; S1
Publicat a
Addiction
Citació
Trapero‐Bertran, Marta; Leidl, Reiner; Muñoz, Celia [et al.]. Estimates of costs for modelling return on investment from smoking cessation interventions. Addiction, 2018, 113(S1), p. 32-41. Disponible en: <https://onlinelibrary.wiley.com/doi/full/10.1111/add.14091>. Fecha de acceso: 24 may. 2020. DOI: 10.1111/add.14091.
Número de l'acord de la subvenció
info:eu-repo/grantAgreement/EC/FP7/602270
Aquest element apareix en la col·lecció o col·leccions següent(s)
Drets
© 2018 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction. This is an open access article under the terms ofthe Creative Commons Attribution-NonCommercialLicense, which permits use, distribution and reproductionin any medium, provided the original work is properly cited and is not used for commercial purposes
Excepte que s'indiqui una altra cosa, la llicència de l'ítem es descriu com https://creativecommons.org/licenses/by-nc/4.0/